Related references
Note: Only part of the references are listed.Metformin, arterial function, intima-media thickness and nitroxidation in metabolic syndrome:: The mefisto study
Eduardo Meaney et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2008)
After ENHANCE: Is more LDL cholesterol lowering even better?
Evan A. Stein
CLINICAL CHEMISTRY (2008)
Effect of lower targets for blood pressure and LDL cholesterol on atherosclerosis in diabetes - The SANDS randomized trial
Barbara V. Howard et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2008)
Simvastatin with or without ezetimibe in familial hypercholesterolemia
John J. P. Kastelein et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Cardiovascular risk factors in the urban Mexican population:: The FRIMEX study
E. Meaney et al.
PUBLIC HEALTH (2007)
Effect of very high-intensity statin therapy on regression of coronary atherosclerosis - The ASTEROID trial
SE Nissen et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Complementary therapy to target LDL cholesterol: the role of the ezetimibe/simvastatin combination
Ryan Neal et al.
VASCULAR HEALTH AND RISK MANAGEMENT (2006)
Improvement in endothelial structure and function after metformin treatment in young normal-weight women with polycystic ovary syndrome: Results of a 6-month study
F Orio et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
Evaluation of C-reactive protein measurement for assessing the risk and prognosis in ischemic stroke - A statement for health care professionals from the CRP pooling project members
M Di Napoli et al.
STROKE (2005)
Carotid intimal-media thickness as a surrogate for cardiovascular disease events in trials of HMG-CoA reductase inhibitors
MA Espeland et al.
CURRENT CONTROLLED TRIALS IN CARDIOVASCULAR MEDICINE (2005)
Prevention and Rehabilitation - Dose-comparison study of the combination of ezetimibe and simvastatin (Vytorin) versus atorvastatin in patients with hypercholesterolemia: The Vytorin Versus Atorvastatin (VYVA) Study
CM Ballantyne et al.
AMERICAN HEART JOURNAL (2005)
Further evidence for interethnic differences in the oral pharmacokinetics of meloxicam
MD Carrasco-Portugal et al.
CLINICAL DRUG INVESTIGATION (2005)
Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis - A randomized controlled trial
SE Nissen et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2004)
Niemann-Pick C1 like 1 protein is critical for intestinal cholesterol absorption
SW Altmann et al.
SCIENCE (2004)
Achieving lipoprotein goals in patients at high risk with severe hypercholesterolemia: Efficacy and safety of ezetimibe co-administered with atorvastatin
E Stein et al.
AMERICAN HEART JOURNAL (2004)
Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines
SM Grundy et al.
CIRCULATION (2004)
Statins in stroke prevention and carotid atherosclerosis -: Systematic review and up-to-date meta-analysis
P Amarenco et al.
STROKE (2004)
Monocyte count, but not C-reactive protein or interleukin-6, is an independent risk marker for subclinical carotid atherosclerosis
CML Chapman et al.
STROKE (2004)
Beneficial cardiovascular pleiotropic effects of statins
J Davignon
CIRCULATION (2004)
Efficacy and safety of a potent new selective cholesterol absorption inhibitor, Ezetimibe, in patients with primary hypercholesterolemia
CA Dujovne et al.
AMERICAN JOURNAL OF CARDIOLOGY (2002)
ARBITER: Arterial biology for the investigation of the treatment effects of reducing cholesterol - A randomized trial comparing the effects of atorvastatin and pravastatin on carotid intima medial thickness
AJ Taylor et al.
CIRCULATION (2002)
Inhibition of intestinal cholesterol absorption by ezetimibe in humans
T Sudhop et al.
CIRCULATION (2002)
MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20536 high-risk individuals: a randomised placebo-controlled trial
R Collins et al.
LANCET (2002)
Carotid intima-media thickness at different sites: relation to incident myocardial infarction - The Rotterdam Study
AI del Sol et al.
EUROPEAN HEART JOURNAL (2002)
How best to combat the enemies? Lipid lowering
SM Cobbe
EUROPEAN HEART JOURNAL SUPPLEMENTS (2002)
Intima-media thickness: a new tool for diagnosis and treatment of cardiovascular risk
A Simon et al.
JOURNAL OF HYPERTENSION (2002)
Epidemiological and nutritional transition in Mexico: rapid increase of non-communicable chronic diseases and obesity
JA Rivera et al.
PUBLIC HEALTH NUTRITION (2002)
Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
JI Cleeman et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
Clinical reality of coronary prevention guidelines:: a comparison of EUROASPIRE I and II in nine countries
K Kotseva et al.
LANCET (2001)
Increased bioavailability of sildenafil in Mexican men
FJ Flores-Murrieta et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2000)
The Lipid Treatment Assessment Project (L-TAP) -: A multicenter survey to evaluate the percentages of dyslipidemic, patients receiving lipid-lowering therapy and achieving low-density lipoprotein cholesterol goals
TA Pearson et al.
ARCHIVES OF INTERNAL MEDICINE (2000)
Share Paper
